Ojo-Fati Olamide, John Florence, Thomas Janet, Joseph Anne M, Raymond Nancy C, Cooney Ned L, Pratt Rebekah, Rogers Charles R, Everson-Rose Susan A, Luo Xianghua, Okuyemi Kolawole S
Department of Family Medicine and Community Health, University of Minnesota Medical School, 717 Delaware Street SE, Suite 166, Minneapolis, MN, 55414, USA.
Program in Health Disparities Research, University of Minnesota Medical School, 717 Delaware Street SE, Suite 166, Minneapolis, MN, 55414, USA.
Trials. 2015 Aug 29;16:385. doi: 10.1186/s13063-015-0858-z.
Despite progress in reducing cigarette smoking in the general U.S. population, smoking rates, cancer morbidity and related heart disease remain strikingly high among the poor and underserved. Homeless individuals' cigarette smoking rate remains an alarming 70% or greater, and this population is generally untreated with smoking cessation interventions. Furthermore, the majority of homeless smokers also abuse alcohol and other drugs, which makes quitting more difficult and magnifies the health consequences of tobacco use.
METHODS/DESIGN: Participants will be randomized to one of three groups, including (1) an integrated intensive smoking plus alcohol intervention using cognitive behavioral therapy (CBT), (2) intensive smoking intervention using CBT or (3) usual care (i.e., brief smoking cessation and brief alcohol counseling). All participants will receive 12-week treatment with a nicotine patch plus nicotine gum or lozenge. Counseling will include weekly individual sessions for 3 months, followed by monthly booster group sessions for 3 months. The primary smoking outcome is cotinine-verified 7-day smoking abstinence at follow-up week 52, and the primary alcohol outcome will be breathalyzer-verified 90-day alcohol abstinence at week 52.
This study protocol describes the design of the first community-based controlled trial (n = 645) designed to examine the efficacy of integrating alcohol abuse treatment with smoking cessation among homeless smokers. To further address the gap in effectiveness of evidence-based smoking cessation interventions in the homeless population, we are conducting a renewed smoking cessation clinical trial called Power to Quit among smokers experiencing homelessness.
ClinicalTrials.gov Identifier: NCT01932996. Date of registration: 20 November 2014.
尽管美国普通人群在减少吸烟方面取得了进展,但贫困和服务不足人群的吸烟率、癌症发病率及相关心脏病发病率仍然极高。无家可归者的吸烟率仍高达70%或更高,令人担忧,而且这一群体通常未接受戒烟干预治疗。此外,大多数无家可归的吸烟者还酗酒及滥用其他药物,这使得戒烟更加困难,并加剧了吸烟对健康的影响。
方法/设计:参与者将被随机分为三组,包括(1)采用认知行为疗法(CBT)的综合强化戒烟加戒酒干预组,(2)采用CBT的强化戒烟干预组,或(3)常规护理组(即简短戒烟和简短酒精咨询)。所有参与者将接受为期12周的治疗,使用尼古丁贴片加尼古丁口香糖或含片。咨询将包括为期3个月的每周一次个体治疗,随后是为期3个月的每月一次强化小组治疗。主要吸烟结局是在随访第52周通过可替宁验证的7天戒烟,主要酒精结局是在第52周通过呼气酒精含量测定仪验证的90天戒酒。
本研究方案描述了首个基于社区的对照试验(n = 645)的设计,旨在检验对无家可归吸烟者进行酗酒治疗与戒烟相结合的疗效。为了进一步弥补无家可归人群中基于证据的戒烟干预措施有效性方面的差距,我们正在开展一项名为“无家可归吸烟者戒烟动力”的新戒烟临床试验。
ClinicalTrials.gov标识符:NCT01932996。注册日期:2014年11月20日。